Statements from the Clinical Reference Group of the Medical Advisory Committee of Family Planning Alliance Australia
The Medical Advisory Committee (MAC) of Family Planning Alliance Australia (FPAA) has published a set of clinical statements addressing various topics in contraception, intended for healthcare practitioners. If you are not a clinician, you may find patient information by viewing our Brochures & Information Sheets page.
The FPAA MAC comprises of senior medical educators, senior medical officers, and medical directors of member family planning organizations. They evaluate current clinical practices and offer evidence-based recommendations supported by consensus, aimed at guiding healthcare practitioners.
These statements cover emerging and recent issues in contraception, providing direction in areas where gaps in evidence exist.
IUDs:
- Extended use of Mirena for contraception
- Malposition and perforation of IUDs
- Pregnancy with an IUD in situ
- Menstrual cups and IUDs
- IUD and cervical cleansing
- The levonorgestrel IUD as Emergency Contraception
Etonogestrel implants (Implanon NXT®):
Combined Hormonal Contraception
- Switching from a combined hormonal method to a progestogen only method
- Decreasing bleeds in users of the pill and vaginal ring
Progestogen Only Oral Contraception
Emergency Contraception
- Ulipristal (Ella 1®) and Breastfeeding
- Ulipristal (Ella 1®) and hormonal contraception
- Oral emergency contraception and further episodes of unprotected sex
Drug interactions with hormonal contraceptives
General contraception issues